In most cases haemoptysis is a self-limiting event but in fewer than 5% it may be severe or massive, representing a life-threatening condition that warrants urgent investigations and treatment.
Despite haemoptysis being regarded as an 'alarm' symptom, no identifiable cause is found in 15-20% of cases and these are termed idiopathic or cryptogenic haemoptysis. [2] Haemoptysis is rare in children and often only presents where bleeding is substantial, as children tend to swallow rather than expectorate their sputum. Respiratory tract infection is the most common cause. Foreign body inhalation is the second most common cause (particularly with younger children) and congenital heart disease and bronchiectasis secondary to cystic fibrosis are other important causes.
Epidemiology
Haemoptysis is common. In most cases, it is mild, self-limiting and related to transitory infection but it should be considered a serious sign due to the risk of underlying pathology.
The relative contribution of different causes depends on the local population. In the past, tuberculosis (TB) was a major cause but, in the UK today, the majority of cases of haemoptysis presenting to primary care are due to acute upper and lower respiratory tract infections, with lung cancer a much smaller but significant cause. [1] Presentation Patients may find it hard to identify the origin of their bleeding.
Haemoptysis or haematemesis?

Haemoptysis Haematemesis
No nausea or vomiting Nausea and vomiting 
Symptoms
Abrupt-onset cough, fever with bloody and purulent sputum -suggestive of acute pneumonia or bronchitis. Chronic productive cough -suggestive of chronic bronchitis or bronchiectasis. Fevers, night sweats and weight loss -consider TB and other infections or malignancy. Anorexia, weight loss and changing cough -think of possible bronchogenic carcinoma. Dyspnoea, fatigue, orthopnoea, paroxysmal nocturnal dyspnoea, frothy pink sputum -suggestive of congestive heart failure. Dyspnoea and pleuritic chest pain -consider a PE.
Signs
Record vital signs, including oxygen saturation levels. Fever, tachycardia, tachypnoea, weight loss and hypoxia are all relevant. Check for cachexia, cyanosis, pallor, ecchymoses, telangiectasias and lymphadenopathy. 
Investigations
Bronchoscopy combined with imaging technology usually identifies the bleeding site in the lungs.
Imaging -CXR +/-CT scan. About 30% of patients with haemoptysis have normal CXRs. A negative CXR warrants other investigations, usually including a bronchoscopy. [1] A CT scan is more sensitive than a CXR. Computed tomography angiography (CTA) can play a crucial role in assessing the cause and origin of the haemoptysis and directing the interventional radiologist prior to treatment. [ 
Minor haemoptysis
Effort should be concentrated on determining the origin of the haemoptysis, providing specific treatment where available and excluding serious underlying pathology.
Normal CXR, history consistent with bronchitis -oral antibiotic, advise smoking cessation and follow-up in a few weeks. Consider chest CT scan and bronchoscopy where: Haemoptysis lasts longer than two weeks. There are recurrent episodes of haemoptysis. The volume of haemoptysis is >30 ml per day. The patient is a smoker and >40 years old. There is suspected bronchiectasis.
All smokers or ex-smokers aged >40 years with persistent haemoptysis should urgently be referred to a chest physician under the two-week wait rules. [4] 
Moderate haemoptysis
Moderate haemoptysis (30-50 ml in the previous 24 hours) requires hospitalisation for observation, due to increased risk of further heavy bleeding.
Major haemoptysis
This is a medical emergency with a high mortality rate. [5] However, there are few large, good-quality, controlled trials looking at best management to guide practice -particularly in the medical versus surgical dilemma.
Resuscitate according to 'ABC' principles. Intubate where there are signs of acute respiratory failure. Selective intubation of the right or left main bronchus with a large single-lumen endotracheal tube or, alternatively, the use of a double lumen tube should be considered. Maintain oxygenation saturations with high flow oxygen and suction. Obtain IV access and give fluids/blood transfusion as appropriate. Correct any clotting abnormalities. The patient will require admission to intensive care.
Localisation of the bleeding site via radiology and early bronchoscopy. CXR and even CT scanning may not be helpful (due to the presence of aspirated blood). The use of rigid or flexible fibreoptic bronchoscopy remains controversial and tends to depend on local preference and expertise. Specific therapies to control bleeding:
Angiography and embolisation -endovascular embolisation is the most effective and minimally invasive technique for managing massive and recurrent haemoptysis. [2] Bronchoscopic therapy:
Iced saline lavage. Topical agents -eg, use of thrombin or fibrinogen-thrombin glue. Endobronchial balloon catheter tamponade. Laser photocoagulation.
Surgical resection:
Segmentectomy. Lobectomy.
Pneumonectomy.
Under emergency conditions, surgery is difficult, has a high risk of septic complications and a significant mortality rate. Surgery is usually only the treatment of choice in selected cases, such as chest trauma and iatrogenic pulmonary artery rupture. Emergency surgery should therefore be reserved for patients with persistent lifethreatening haemoptysis. [6] Radiotherapy -may be used to treat aspergillomas and vascular tumours. Antifibrinolytic therapy -although there is currently insufficient evidence to determine whether antifibrinolytics can be used to treat haemoptysis from any cause, there is limited evidence to suggest they may reduce the duration of bleeding. [6] Palliative care [7] Haemoptysis is the presenting complaint in 7-10% of lung cancers and about 20-30% of patients with lung cancer will experience it over the course of their illness.
Management of haemoptysis in the context of a malignant disease depends on the volume of blood loss, its cause (bleeding may not be related to tumour progression; thromboembolic disease or infection may also cause it) and prognosis.
Given the bleak prognosis of a massive haemoptysis, active resuscitation may not be desired or appropriate. Under these circumstances, the emphasis should be on the relief of pain and of fear in the patient and supporting witnesses and family:
Nurse the patient lying on the side of the tumour. Administer parenteral opioid and fast-acting benzodiazepine. Mask blood with red or green towels.
In some, the likelihood of such a bleed can be predicted (based on the tumour site, earlier bleeds, etc) and it may be appropriate to discuss and plan for such an eventuality with the patient and their family.
Where active treatment is desired, management of a major bleed is as above. With more minor haemoptysis, additional palliative care measures may include:
Oral haemostatics -eg, tranexamic acid. Cough suppression. Anticoagulation (where PE). Antibiotics (where infection). Radiotherapy or laser treatment of the tumour site. Therapeutic bronchoscopy with balloon tamponade and infusion of vasoactive agents such as adrenaline (epinephrine) may be successful. Bronchial angiography with bronchial artery embolisation can sometimes control haemoptysis.
Prognosis
Haemoptysis may be a mild, self-limiting symptom or may herald serious underlying disease. Massive haemoptysis can directly cause death and has a bad prognosis, worse in some groups such as those with an underlying cancer. 
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